EcoDrugPlus

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSMOCG00000013721
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type

Ensembl ID : ENSMOCG00000009911
Gene Symbol: LOC101983331
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSMOCG00000006115
Gene Symbol: ALOX5
3 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSMOCG00000018258
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSMOCG00000002679
Gene Symbol: AVPR1B
3 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMOCG00000012257
Gene Symbol: AVPR2
3 Cross references
231 Possible Orthologues:

Aromatase

Ensembl ID : ENSMOCG00000007758
Gene Symbol: LOC101983205
3 Cross references
315 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSMOCG00000016038
Gene Symbol: AHR
3 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMOCG00000005866
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMOCG00000010954
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSMOCG00000008593
Gene Symbol: AURKC
3 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMOCG00000011148
Gene Symbol: BACE1
3 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).